AN2 Therapeutics, Inc. (ANTX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $53.06M | -35.2% |
| 2024 | $81.85M | -34.4% |
| 2023 | $124.70M | +30.8% |
| 2022 | $95.37M | +301.2% |
| 2021 | -$47.41M | -133.3% |
| 2020 | -$20.32M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $53.06M | -35.2% |
| 2024 | $81.85M | -34.4% |
| 2023 | $124.70M | +30.8% |
| 2022 | $95.37M | +301.2% |
| 2021 | -$47.41M | -133.3% |
| 2020 | -$20.32M | — |